Healthcare Quality, Patient Safety & PolicyChiesi, Protalix Gain EU Approval for New Elfabrio DosingGlobeNewswireMarch 9, 2026March 11, 2026 by GlobeNewswireMarch 9, 2026March 11, 2026019 This press release from Chiesi is intended for US audiences for transparency relative to global news for the Fabry community. This dosing regimen for Elfabrio...